Heat shock protein 27: Clue to understanding estrogen-mediated atheroprotection?

Trends in Cardiovascular Medicine

Volumn 20, Issue 2, 2010, Pages 53-57

  Rayner, Katey ^a   Chen, Yong Xiang ^a   Siebert, Tara ^a   O'Brien, Edward R ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; HEAT SHOCK PROTEIN 27; SCAVENGER RECEPTOR A; LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; CHOLESTEROL TRANSPORT; ESTROGEN THERAPY; GENE OVEREXPRESSION; HEART PROTECTION; HUMAN; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SECRETION; REVIEW; VASCULAR DISEASE; VASCULITIS; ANIMAL; ATHEROSCLEROSIS; BLOOD; DISEASE MODEL; FEMALE; METABOLISM; MOUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); WOMEN'S HEALTH;

ANIMALS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; HSP27 HEAT-SHOCK PROTEINS; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MICE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WOMEN'S HEALTH;

EID: 77955063824     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.03.008     Document Type: Review

References (36)

1. Arnal J.F., Scarabin P.Y., Tremollieres F., et al. Estrogens in vascular biology and disease: where do we stand today?. Curr Opin Lipidol 2007, 18:554-560.
2. Billon-Gales A., Fontaine C., Douin-Echinard V., et al. Endothelial estrogen receptor-α plays a crucial role in the atheroprotective action of 17δ-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 2009, 120:2567-2576.
3. Bourassa P.A., Milos P.M., Gaynor B.J., et al. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci 1996, 93:10022-10027.
4. Cavailles V., Dauvois S., L'Horset F., et al. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 1995, 14:3741-3751.
5. Chen H., Hewison M., Adams J.S. Control of estradiol-directed gene transactivation by an intracellular estrogen-binding protein and an estrogen response element-binding protein. Mol Endocrinol 2008, 22:559-569.
6. Chen Y.-X., Zhao X., McNulty M., O'Brien E.R. Recombinant HSP27 therapy reduces serum cholesterol levels and experimental atherogenesis. Circulation 2009, 120:S1153.
7. Christian R.C., Liu P.Y., Harrington S., et al. Intimal ERβ but not ERα expression is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. J Clin Endocrinol Metab 2006, 91:2713-2720.
8. De Souza A.I., Wait R., Mitchell A.G., et al. Heat shock protein 27 is associated with freedom from graft vasculopathy after human cardiac transplantation. Circ Res 2005, 97:192-198.
9. DuSell C.D., Umetani M., Shaul P.W., et al. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol Endocrinol 2008, 22:65-77.
10. Egan K.M., Lawson J.A., Fries S., et al. COX-2-derived prostacyclin confers atheroprotection on female mice. Science 2004, 306:1954-1957.
11. Elhage R., Arnal J.-F., Pieraggi M.-T., et al. 17δ-Estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1997, 17:2679-2684.
12. Hanstein B., Eckner R., DiRenzo J., et al. p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci USA 1996, 93:11540-11545.
13. Hodges Y.K., Tung L., Yan X.D., et al. Estrogen receptors α and β: prevalence of estrogen receptor α mRNA in human vascular smooth muscle and transcriptional effects. Circulation 2000, 101:1792-1798.
14. Hodgin J.B., Maeda N. Minireview: estrogen and mouse models of atherosclerosis. Endocrinology 2002, 143:4495-4501.
15. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA: The Journal of the American Medical Association 1998, 280:605-613.
16. Jazbutyte V., rias-Loza P.A., Hu K., et al. Ligand-dependent activation of ERβ lowers blood pressure and attenuates cardiac hypertrophy in ovariectomized spontaneously hypertensive rats. Cardiovasc Res 2008, 77:774-781.
17. Kim E.S.H., Carrigan T.P., Menon V. Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion. J Am Coll Cardiol 2008, 52:672-673.
18. Lindner V., Kim S.K., Karas R.H., et al. Increased expression of estrogen receptor-β mRNA in male blood vessels after vascular injury. Circ Res 1998, 83:224-229.
19. Liu P.Y., Christian R.C., Ruan M., et al. Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease. J Clin Endocrinol Metab 2005, 90:1041-1046.
20. Mackman N., Smyth S. Cardiovascular disease in women. Arterioscler Thromb Vasc Biol 2009, 29:277-278.
21. Manson J.E., Allison M.A., Rossouw J.E., et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007, 356:2591-2602.
22. Martin-Ventura J.L., Duran M.C., Blanco-Colio L.M., et al. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 2004, 110:2216-2219.
23. Martin-Ventura J.L., Nicolas V., Houard X., et al. Biological significance of decreased HSP27 in human atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26:1337-1343.
24. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N Eng J Med 1999, 340:1801-1811.
25. Miller H., Poon S., Hibbert B., et al. Modulation of estrogen signaling by the novel interaction of heat shock protein 27, a biomarker for atherosclerosis, and estrogen receptor δ. Arterioscler Thromb Vasc Biol 2005, 25:e10-e14.
26. O'Brien E.R., Zhao X., Rayner K., Chen Y.-X. Over-expression of the estrogen receptor β associated protein HSP27 is atheroprotective. Cell Stress & Chaperones 2007, 12:173.
27. O'Malley B.W., McKenna N.J. Coactivators and corepressors: what's in a name?. Mol Endocrinol 2008, 22:2213-2214.
28. Rayner K., Chen Y.-X., McNulty M., et al. Extracellular release of the atheroprotective heat shock protein 27 is mediated by estrogen and competitively inhibits acLDL binding to scavenger receptor-A. Circ Res 2008, 103:133-141.
29. Rayner K., Sun J., Chen Y.X., et al. Heat shock protein 27 protects against atherogenesis via an estrogen-dependent mechanism: role of selective estrogen receptor β modulation. Arterioscler Thromb Vasc Biol 2009, 29:1751-1756.
30. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333.
31. Rossouw J.E., Prentice R.L., Manson J.E., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007, 297:1465-1477.
32. Stampfer M.J., Colditz G.A., Willett W.C., et al. Postmenopausal estrogen therapy and cardiovascular disease-ten-year follow-up from the Nurses' Health Study. N Engl J Med 1991, 325:756-762.
33. Sun J., Ma X., Rayner K., et al. Selective activation of estrogen receptor β attenuates atherogenesis and represses cholesterol-associated immune-inflammatory responses. Circulation 2008, 118:S482.
34. Towfighi A., Zheng L., Ovbiagele B. Sex-specific trends in midlife coronary heart disease risk and prevalence. Arch Intern Med 2009, 169:1762-1766.
35. Villablanca A., Lubahn D., Shelby L., et al. Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor-α. Arterioscler Thromb Vasc Biol 2004, 24:1055-1061.
36. Villablanca A.C., Tenwolde A., Lee M., et al. 17β-estradiol prevents early-stage atherosclerosis in estrogen receptor-α deficient female mice. J Cardiovasc Transl Res 2009, 2:289-299.